Oral Cavity Carcinoma — Trials

Oral Cavity Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

310 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 94
Recruiting: 43
Ph III recruiting: 9
Growth YoY: +13.6%
Industry share: 6%
Top sponsor: National Cancer Institute (NCI)
Termination share: 33.6%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (38)

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT03784066	Durvalumab With or Without Tremelimumab in Resectable Locally Advanced Squamous Cell Carcinoma of the Oral Cavity(DUTRELASCO)	unknown	Phase 1 / Phase 2	21	Universitaire Ziekenhuizen KU LeuvenOTHER	1	Jul 3, 2024	clinicaltrials
NCT03843515	Neoadjuvant Nivolumab for Oral Cancer Combined With FDG and Anti-PD-L1 PET/CT Imaging for Response Prediction(NeoNivo)	unknown	Phase 1	17	Amsterdam UMC, location VUmcOTHER